01 August 2005 :
The use of recombinant human activated protein C (rhAPC) in the treatment of severe sepsis in immunosuppressed patients in the course of hematological diseases.
Med Sci Monit 2005; 11(8): CS49-55 :: ID: 202172
HTML version available soon